FIRST AMENDMENT TO MULTICURRENCY NOTE PURCHASE AND PRIVATE SHELF AGREEMENTMulticurrency Note Purchase and Private Shelf Agreement • March 15th, 2019 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances • New York
This FIRST AMENDMENT TO MULTICURRENCY NOTE PURCHASE AND PRIVATE SHELF AGREEMENT, dated as of March 14, 2019 (the “First Amendment”) is made by and among IDEXX Laboratories, Inc., a Delaware corporation (the “Company”), each of the Subsidiary Guarantors set forth on the signature pages to this First Amendment (together with the Company, collectively, the “Credit Parties”), Metropolitan Life Insurance Company (“MetLife”), and each of the holders of the Notes (as defined below) set forth on the signature pages to this First Amendment (collectively, the “Noteholders”).
Second Amendment To Multicurrency Note Purchase and Private Shelf AgreementMulticurrency Note Purchase and Private Shelf Agreement • March 27th, 2020 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances • New York
This Second Amendment to Multicurrency Note Purchase and Private Shelf Agreement, dated as of March 23, 2020 (this “Second Amendment”), is made by and among IDEXX Laboratories, Inc., a Delaware corporation (the “Company”), each of the Subsidiary Guarantors set forth on the signature pages to this Second Amendment (together with the Company, collectively, the “Credit Parties”), MetLife Investment Management, LLC (formerly known as MetLife Investment Advisors, LLC) (“MetLife”), and each of the holders of the Notes (as defined below) set forth on the signature pages to this Second Amendment (collectively, the “Noteholders”).
IDEXX LABORATORIES, INC. $75,000,000 3.25% Series A Senior Notes due February 12, 2022 $75,000,000 3.72% Series B Senior Notes due February 12, 2027 $50,000,000 (or Foreign Currency Equivalent) Private Shelf Facility MULTICURRENCY NOTE PURCHASE AND...Multicurrency Note Purchase and Private Shelf Agreement • December 29th, 2014 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances • New York
IDEXX Laboratories, Inc., a Delaware corporation (together with any successor thereto that becomes a party hereto pursuant to Section 10.3, the “Company”), agrees with MetLife and each of the Purchasers as follows:
50,000,000 (or Foreign Currency Equivalent) Private Shelf Facility MULTICURRENCY NOTE PURCHASE AND PRIVATE SHELF AGREEMENT Dated December 19, 2014Multicurrency Note Purchase and Private Shelf Agreement • March 15th, 2019 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances • New York
IDEXX Laboratories, Inc., a Delaware corporation (together with any successor thereto that becomes a party hereto pursuant to Section 10.3, the “Company”), agrees with MetLife and each of the Purchasers as follows:
